A phase 2 study of DS109 for the treatment of inflammatory skin disorders.

Trial Profile

A phase 2 study of DS109 for the treatment of inflammatory skin disorders.

Planning
Phase of Trial: Phase II

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Dihomo-gamma linolenic acid (Primary)
  • Indications Skin disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2017 New trial record
    • 06 Jan 2017 According to a DS Biopharma media release, this trial is expected to start later this year.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top